Dogwood Therapeutics DWTX Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Dogwood Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dogwood Therapeutics's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dogwood Therapeutics's total liabilities & equity?
- Dogwood Therapeutics (DWTX) reported total liabilities & equity of $95.21M in Q1 2026.
- How has Dogwood Therapeutics's total liabilities & equity changed year-over-year?
- Dogwood Therapeutics's total liabilities & equity decreased by 1.8% year-over-year, from $96.98M to $95.21M.
- What is the long-term trend for Dogwood Therapeutics's total liabilities & equity?
- Over 5 years (2020 to 2025), Dogwood Therapeutics's total liabilities & equity has grown at a 23.4% compound annual growth rate (CAGR), from $31.47M to $90.17M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.